Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

ALAMEDA, Calif., Oct. 27, 2016 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Event:

Canaccord Genuity Medical Technologies & Diagnostics Forum

Date:

Thursday, November 17, 2016

Time:

2:30pm ET / 11:30am PT

An audio webcast of the presentation will be available by visiting the investors section of the company’s website at www.penumbrainc.com. The webcast will be available on the company’s website for two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com

Logo – http://photos.prnewswire.com/prnh/20151029/282131LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-medical-technologies–diagnostics-forum-300352775.html

SOURCE Penumbra, Inc.